Director, Tommy’s National Centre for Miscarriage Research,
Institute of Metabolism and Systems Research, University of Birmingham, UK
Professor Arri Coomarasamy's research interests are in fertility, early pregnancy and global women's health. He received his undergraduate medical education from the University of Birmingham, and completed his subspecialist training in reproductive medicine and surgery at Guy’s Hospital, London.
Professor Coomarasamy serves on several international and national committees which include including Joint Global Health Trials Panel of Wellcome Trust, Medical Research Council, and Department for International Development, various World Health Organisation committees, and the Early Pregnancy Clinical Studies Group. He is the Director of Tommy's National Centre for Miscarriage Research. This is the largest miscarriage research Centre in Europe, with specialist research teams at the University of Birmingham, University of Warwick and Imperial College, London. He also is the founding trustee of Ammalife, a UK-registered charity with a global mission to reduce maternal deaths in low-income countries.
Professor Coomarasamy’s portfolio includes numerous national and international multicentre randomised controlled trials, including the PROMISE trial, the TABLET Trial, the PRISM Trial, the RESPONSE Trial, the AIMS trial and the WHO CHAMPION trial. His research has resulted in the publication of over 140 research articles in high-impact journals such as the New England Journal of Medicine, the Lancet, the British Medical Journal and Human Reproduction. He is also the author of 5 medical textbooks and over 40 medical chapters, including an award winning book on “Assisted Conception Treatment: Challenges and Management Options”.